Surmodics, Inc. (SRDX)
NASDAQ: SRDX · Real-Time Price · USD
36.90
-0.44 (-1.18%)
At close: Aug 20, 2025, 4:00 PM
36.90
0.00 (0.00%)
After-hours: Aug 20, 2025, 4:10 PM EDT
Surmodics Employees
Surmodics had 389 employees as of September 30, 2024. The number of employees increased by 13 or 3.46% compared to the previous year.
Employees
389
Change (1Y)
13
Growth (1Y)
3.46%
Revenue / Employee
$310,542
Profits / Employee
-$45,314
Market Cap
527.58M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 389 | 13 | 3.46% |
| Sep 30, 2023 | 376 | -71 | -15.88% |
| Sep 30, 2022 | 447 | 58 | 14.91% |
| Sep 30, 2021 | 389 | 19 | 5.14% |
| Sep 30, 2020 | 370 | 1 | 0.27% |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SRDX News
- 12 days ago - Surmodics Reports Third Quarter of Fiscal Year 2025 Financial Results; Updates Fiscal Year 2025 Financial Guidance - Business Wire
- 14 days ago - Surmodics to Report Third Quarter of Fiscal 2025 Financial Results on August 8 - Business Wire
- 4 months ago - Surmodics Reports Second Quarter of Fiscal Year 2025 Financial Results; Introduces Fiscal Year 2025 Financial Guidance - Business Wire
- 4 months ago - Surmodics to Report Second Quarter of Fiscal 2025 Financial Results on April 30 - Business Wire
- 4 months ago - Surmodics Announces Publication of TRANSCEND Trial, Highlighting Drug-Delivery Technology of its SurVeil™ Drug-Coated Balloon - Business Wire
- 4 months ago - Surmodics Announces Commercial Release of Pounce™ XL Thrombectomy System, Enabling Rapid Non-Surgical Clot Removal in Iliac and Femoral Arteries - Business Wire
- 5 months ago - Surmodics Issues Statement on U.S. Federal Trade Commission Challenge to Proposed Acquisition of Surmodics by Funds Affiliated with GTCR - Business Wire
- 5 months ago - FTC sues to block private equity firm's deal to buy medical device coatings maker Surmodics - Reuters